Baker Brothers Life Sciences LP, Director, 10% Owner at BeiGene, Ltd. (BGNE), sold 1,100,000 shares at $180.50 ($198.6M) on 2023-11-14, disclosed to the SEC on 2023-11-14.
Open-market sale of $198.6M BGNE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $180.50 | 91,340 | $16.5M | 8.3% |
| 2 | $180.50 | 1,008,660 | $182.1M | 91.7% |
| Total | $180.50 avg | 1,100,000 | $198.6M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| NLTX | BUY | 2023-08-17 | $2.9M | — | Filing → |